Krka, d.d.
KRKG · LJSE · Pharmaceuticals
About the company
Krka is Slovenia's largest company by market capitalisation and one of Europe's leading generic pharmaceutical manufacturers, founded in 1954 and headquartered in Novo Mesto. The company develops, manufactures, and markets prescription drugs, over-the-counter products, and veterinary medicines across over 70 countries, with particularly strong positions in Central and Eastern Europe and Russia. In 2024 the group reported revenues of approximately €1.9 billion and its highest-ever operating profit of €408 million.
| Exchange | LJSE |
| Ticker | KRKG |
| Sector | Pharmaceuticals |
| Indicative market cap USD | $8.60B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (LJSE), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Ljubljana Stock Exchange — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in Slovenia
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.